NEW YORK — The US Food and Drug Administration has awarded researchers from Vanderbilt University a roughly $2.4 million grant to identify genetic and other biomarkers that can be used to determine the severity and progression of cardiac dysfunction associated with Duchenne muscular dystrophy (DMD).